Ironwood Pharmaceuticals
Manufacturing · Massachusetts, United States · 267 Employees
View Company Info for Free
About
Headquarters
125 Binney St, Cambridge, Massachusetts, 02142,...Phone Number
(617) 621-8097Website
www.ironwoodpharma.comRevenue
$400.6 MillionStock Symbol
IRWDIndustry
Most Recent Scoops
Highlights
$1.4B
Total Funding Amount
$341M
Most Recent Funding Amount
11
Number of Funding Rounds
Who is Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company sp ecializing in gastrointestinal pharmaceutical solutions.Read more
Popular Searchesironwood pharmaceuticals IncIronwood PharmaceuticalsIronwood Pharmaceuticals GmbHIronwood IncAxiom Capital Group IncSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: IRWDShow moreIronwood Pharmaceuticals Org Chart
Is Ironwood Pharmaceuticals your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ironwood Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ironwood Pharmaceuticals
Funding: Get notified immidiatlly once Ironwood Pharmaceuticals has new funding data
Earning: See what the market has to say on Ironwood Pharmaceuticals recently announced quarterly report
Click to see if Ironwood Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Ironwood Pharmaceuticals launches new products
Ironwood Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ironwood Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Ironwood Pharmaceuticals
Find 2 more new buyers
Similar Companies to Ironwood Pharmaceuticals
Analyze insights from companies similar to Ironwood Pharmaceuticals and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Heron Therapeutics126$136.4M
- Deciphera355$174.9M
- Lexicon Pharmaceuticals285<$5M
- Theravance Biopharma99$62M
- Karyopharm Therapeutics325$145.7M
- Akebia Therapeutics167$187.2M
- Puma Biotechnology185$219.1M
- MyoKardia98$43.3M
More similar companies
Ironwood Pharmaceuticals financials insights
Gather financial insights about Ironwood Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Ironwood Pharmaceuticals Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Ironwood Pharmaceuticals Tech Stack
A closer look at the technologies used by Ironwood Pharmaceuticals
Most Recent Scoops
Ironwood Pharmaceuticals News & Media
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. “We continued to make progress across our portfolio in the second quarter,” said Tom McCourt, chief executive officer of Ironwood Pharmaceuticals. “LINZESS prescription demand and new-to-brand growth remain robust, increasing 11% and 15% year-over-year in Q2, respectively. While demand is up, LINZESS continues toIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 8, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 2530602. To access the webcast, please visit the Investors section of Ironwood’s website at www.iroIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City. A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood websiIronwood Pharmaceuticals CMO sells shares worth over $100k - Investing.com
Ironwood Pharmaceuticals CMO sells shares worth over $100k
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in gastrointestinal pharmaceutical solutions.... Read More